NailQoL: A quality-of-life instrument for onychomycosis

International Journal of Dermatology

Volumn 46, Issue 12, 2007, Pages 1279-1286

  Warshaw, Erin M ^a,b   Foster, Jovonne K ^c   Cham, Peter M H ^a   Grill, Joseph P ^b   Chen, Suephy C ^c,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TERBINAFINE;

ADULT; AGED; ANNOYANCE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE EXACERBATION; DRUG DOSE COMPARISON; EMOTION; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAIL QUALITY OF LIFE INSTRUMENT; PAIN; QUALITY OF LIFE; QUALITY OF LIFE INDEX; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK ASSESSMENT; SKIN DISEASE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TOENAIL ONYCHOMYCOSIS; VALIDITY;

AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC STUDIES; FEMALE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MALE; MIDDLE AGED; ONYCHOMYCOSIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE; STATISTICS, NONPARAMETRIC;

EID: 37549046793     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03362.x     Document Type: Article

References (14)

1. Elewski BE. The effect of toenail onychomycosis on patient quality of life. Int J Dermatol 1997; 36: 754-756.
2. Lubeck DP. Measuring health-related quality of life in onychomycosis. J Am Acad Dermatol 1998; 38: S64-S68.
3. Drake LA, Patrick DL, Fleckman P, et al. The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999; 41: 189-196.
4. Schein JR, Gause D, Steire DM, et al. Onychomycosis: Baseline results of an observational study. J Am Pod Med Assoc 1997; 87: 512-519.
5. Whittam LR, Hay RJ. The impact of onychomycosis on quality of life. Clin Exp Dermatol 1997; 22: 87-89.
6. Firooz A, Khamesipour A, Dowlati Y. Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis. J Dermatol Treat 2003; 14: 95-98.
7. Alam M, Moossavi M, Ginsburg I, Scher RK. A psychometric study of patients with nail dystrophies. J Am Acad Dermatol 2001; 45: 851-856.
8. Lubeck DP, Patrick DL, McNulty P, Fifer SK, Birnbaum J. Quality of life of persons with onychomycosis. Qual Life Res 1993; 2: 341-348.
9. Warshaw EM, Fett DD, Bloomfield HE, et al. Pulse vs. continuous terbinafine for onychomycosis: A double-blind, randomized, controlled trial. J Am Acad Dermatol 2005; 53: 578-84.
10. Lubeck DP, Gause D, Schein JR, et al. A health-related quality of life measure for use in patients with onychomycosis: A validation study. Qual Life Res 1999; 8: 121-129.
11. Turner RR, Testa MA. Measuring the impact of onychomycosis on patient quality of life. Qual Life Res 2000; 9: 39-53.
12. Chren MM, Lasek RJ, Flocke SA, et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-40.
13. Allen MJ, Yen WM. Introduction to Measurement Theory. Monterey, CA: Brooks Cole, 1997.
14. Teisl MF, Boyle KJ, McCollum DW, et al. Test-retest reliability of contingent valuation with independent sample pretest and posttest control groups. Am J Agric Econ 1995; 77: 613-619.